Guangzhou Joyo Pharmatech Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 30, 2027The maintenance fee for Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases (US 10,604,513) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,604,513 | Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 11,198,686 | Crystal form and salt form of pyridone compound and preparation method therefor In force · From the USPTO record | In force | From the USPTO record | |
| US 12,351,590 | Pyrrolopyrimidine compound and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,661,357 | Use of Pyrido[1,2-a]pyrimidone Analogue In force · High confidence | In force | High confidence | |
| US 12,622,912 | Application of Pyrido[1,2-a]pyrimidinone Analog In force · High confidence | In force | High confidence | |
| US 12,497,412 | Compound as highly selective ROS1 inhibitor and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,734,177 | Macrocyclic Derivative and Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 12,458,647 | Macrocyclic Derivative and Use Thereof In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 2 no status recorded